Role of Vasopressin in the Regulation of Renal Sodium Excretion: Interaction with Glucagon-Like Peptide-1

Journal of Neuroendocrinology

Volumn 28, Issue 4, 2016, Pages

  Kutina, A V ^a   Golosova, D V ^a   Marina, A S ^a   Shakhmatova, E I ^a   Natochin, Y V ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

GLP 1; Natriuresis; V1a receptor; V2 receptor; Vasopressin

Indexed keywords

ANTIDIURETIC AGENT; GLUCAGON LIKE PEPTIDE 1; HYPERTONIC SOLUTION; INCRETIN; SODIUM; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR; EXENDIN 4; PEPTIDE; SODIUM CHLORIDE; V1A VASOPRESSIN RECEPTOR, RAT; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR; VASOPRESSIN RECEPTOR ANTAGONIST; VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIURESIS; ARTICLE; CONTROLLED STUDY; FEMALE; FREE WATER CLEARANCE; GLOMERULUS FILTRATION RATE; HYPERNATREMIA; HYPEROSMOLARITY; NATRIURESIS; NONHUMAN; OSMOREGULATION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; RAT; RECEPTOR BLOCKING; SALT LOADING; SODIUM ABSORPTION; SODIUM BALANCE; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM LOAD; SODIUM URINE LEVEL; URINARY FRACTIONAL EXCRETION; URINE LEVEL; VASOPRESSIN RELEASE; VASOPRESSIN URINE LEVEL; WATER ABSORPTION; AGONISTS; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; KIDNEY; METABOLISM; OSMOLARITY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; ANTIDIURETIC HORMONE RECEPTOR ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; GLUCAGON-LIKE PEPTIDE 1; KIDNEY; NATRIURESIS; OSMOLAR CONCENTRATION; PEPTIDES; RATS; RECEPTORS, VASOPRESSIN; SALINE SOLUTION, HYPERTONIC; SODIUM; VASOPRESSINS; VENOMS;

EID: 84964961841     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12367     Document Type: Article

References (56)

1. Laycock JF, ed. Perspectives on Vasopressin. London: Imperial College Press, 2010.
2. Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 2002; 283: F221-F235.
3. Balment RJ, Brimble MJ, Forsling ML, Musabayane CT. Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range. J Physiol 1984; 352: 517-526.
4. Musabayane CT, Forsling ML, Balment RJ. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors. Ren Fail 1997; 19: 23-32.
5. Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol 2008; 19: 1721-1731.
6. 2 receptor-mediated effects. Cardiovasc Res 2001; 51: 372-390.
7. Knepper MA, Kim GH, Fernandez-Llama P, Ecelbarger CA. Regulation of thick ascending limb transport by vasopressin. J Am Soc Nephrol 1999; 10: 628-634.
8. 2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 2007; 293: F1166-F1177.
9. Stockand JD. Vasopressin regulation of renal sodium excretion. Kidney Int 2010; 78: 849-856.
10. Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gomez R, Eng J, Blazquez E. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J Neurochem 1996; 67: 1982-1991.
11. Bojanowska E, Stempniak B. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation. Physiol Behav 2003; 78: 73-79.
12. Natochin YV, Marina AS, Kutina AV. The role of incretin as an integrator of sodium and water balance regulation. Dokl Biol Sci 2014; 458: 271-274.
13. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 1986; 63: 492-498.
14. Cho YM, Fujita Y, Kieffer TJ. Glucagon-like peptide-1: glucose homeostasis and beyond. Annu Rev Physiol 2014; 76: 535-559.
15. Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, Girardi AC. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. Am J Physiol Renal Physiol 2011; 301: F355-F363.
16. Thomson SC, Kashkouli A, Singh P. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat. Am J Physiol Renal Physiol 2013; 304: F137-F144.
17. de Rouffignac C, Corman B. Stimulation by antidiuretic hormone of electrolyte tubular reabsorption in rat kidney. Am J Physiol 1983; 244: F156-F164.
18. Yamada K, Goto A, Nagoshi H, Terano Y, Omata M. Elevation of ouabainlike compound levels with hypertonic sodium chloride load in rat plasma and tissues. Hypertension 1997; 30: 94-98.
19. Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na, K pump ligands are differentially regulated during acute NaCl loading of Dahl rats. Circulation 2000; 102: 3009-3014.
20. Kutina AV, Marina AS, Shakhmatova EI, Natochin YV. Vasotocin analogues with selective natriuretic, kaliuretic and antidiuretic effects in rats. Regul Pept 2013; 185: 57-64.
21. Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res 2008; 170: 473-512.
22. Camps J, Sola J, Arroyo V, Rimola A, Perez-Ayuso RM, Gaya J, Rivera F, Rodes J. Tecnicas para el estudio de la excrecion renal de agua libre en ratas normales y con cirrosis hepatica experimental. Rev Esp Fisiol 1986; 42: 117-122.
23. Chen YC, Cadnapaphornchai MA, Yang J, Summer SN, Falk S, Li C, Wang W, Schrier RW. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. Am J Physiol Renal Physiol 2005; 289: F672-F678.
24. Zamoshchina TA, Novitskaya LN, Ivanova EV, Matveenko AV, Saratikov AS. Effects of the anion type and the time of administration of lithium salts on the circadian dynamics of lithium urinary excretion in rats. Pharm Chem J 2005; 39: 283-285.
25. Kutina AV, Marina AS, Shakhmatova EI, Natochin YV. Physiological mechanisms for the increase in renal solute-free water clearance by a glucagon-like peptide-1 mimetic. Clin Exp Pharmacol Physiol 2013; 40: 510-517.
26. McKinley MJ, Lichardus B, McDougall JG, Weisinger RS. Periventricular lesions block natriuresis to hypertonic but not isotonic NaCl loads. Am J Physiol Renal Physiol 1992; 262: F98-F107.
27. Singer DR, Markandu ND, Buckley MG, Miller MA, Sagnella GA, MacGregor GA. Contrasting endocrine responses to acute oral compared with intravenous sodium loading in normal humans. Am J Physiol 1998; 274: F111-F119.
28. Andersen LJ, Andersen JL, Pump B, Bie P. Natriuresis induced by mild hypernatremia in humans. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1754-R1761.
29. Chen S, Grigsby CL, Law CS, Ni X, Nekrep N, Olsen K, Humphreys MH, Gardner DG. Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents. J Clin Invest 2009; 119: 1647-1658.
30. Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM. Neuroendocrine control of body fluid metabolism. Physiol Rev 2004; 84: 169-208.
31. 2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 2005; 16: 1920-1928.
32. Blanchard A, Frank M, Wuerzner G, Peyrard S, Bankir L, Jeunemaitre X, Azizi M. Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent. Clin J Am Soc Nephrol 2011; 6: 753-759.
33. Sam R, Feizi I. Understanding hypernatremia. Am J Nephrol 2012; 36: 97-104.
34. Metzler GH, Thrasher TN, Keil LC, Ramsay DJ. Endocrine mechanisms regulating sodium excretion during water deprivation in dogs. Am J Physiol 1986; 251: R560-R568.
35. McKinley MJ, Evered MD, Mathai ML. Renal Na excretion in dehydrated and rehydrated adrenalectomized sheep maintained with aldosterone. Am J Physiol Regul Integr Comp Physiol 2000; 279: R17-R24.
36. Jia Z, Liu G, Sun Y, Kakizoe Y, Guan G, Zhang A, Zhou SF, Yang T. mPGES-1-derived PGE2 mediates dehydration natriuresis. Am J Physiol Renal Physiol 2013; 304: F214-F221.
37. Verbalis JG, Dohanics J. Vasopressin and oxytocin secretion in chronically hyposmolar rats. Am J Physiol Regul Integr Comp Physiol 1991; 261: R1028-R1038.
38. Windle RJ, Forsling ML, Smith CP, Balment RJ. Patterns of neurohypophysial hormone release during dehydration in the rat. J Endocrinol 1993; 137: 311-319.
39. Greenwood MP, Mecawi AS, Hoe SZ, Mustafa MR, Johnson KR, Al-Mahmoud GA, Elias LL, Paton JF, Antunes-Rodrigues J, Gainer H, Murphy D, Hindmarch CC. A comparison of physiological and transcriptome responses to water deprivation and salt loading in the rat supraoptic nucleus. Am J Physiol Regul Integr Comp Physiol 2015; 308: R559-R568.
40. Prager-Khoutorsky M, Bourque CW. Mechanical basis of osmosensory transduction in magnocellular neurosecretory neurones of the rat supraoptic nucleus. J Neuroendocrinol 2015; 27: 507-515.
41. Balment RJ, Brimble MJ, Forsling ML. Release of oxytocin induced by salt loading and its influence on renal excretion in the male rat. J Physiol 1980; 308: 439-449.
42. Verbalis JG, Mangione MP, Stricker EM. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology 1991; 128: 1317-1322.
43. Huang W, Lee SL, Arnason SS, Sjoquist M. Dehydration natriuresis in male rats is mediated by oxytocin. Am J Physiol Regul Integr Comp Physiol 1996; 270: R427-R433.
44. Soares TJ, Coimbra TM, Martins AR, Pereira AG, Carnio EC, Branco LG, Albuquerque-Araujo WI, de Nucci G, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci USA 1999; 5: 278-283.
45. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
46. Saito M, Tahara A, Sugimoto T, Abe K, Furuichi K. Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor. Eur J Pharmacol 2000; 401: 289-296.
47. Busnelli M, Bulgheroni E, Manning M, Kleinau G, Chini B. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors. J Pharmacol Exp Ther 2013; 346: 318-327.
48. 2 receptors. Am J Physiol Regul Integr Comp Physiol 1995; 269: R193-R200.
49. Cowley AW. Control of the renal medullary circulation by vasopressin V1 and V2 receptors in the rat. Exp Physiol 2000; 85S: 223S-231S.
50. Grider J, Falcone J, Kilpatrick E, Ott C, Jackson B. Effect of luminal vasopressin on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol 1996; 313: 115-118.
51. Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev 2012; 92: 1813-1864.
52. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 1993; 92: 2339-2345.
53. 2 de la vasopressine le long du nephron de mammifere. C R Seances Soc Biol Fil 1995; 189: 151-167.
54. Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK, Herzig KH. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept 2008; 149: 70-78.
55. Ahren B, Carr RD, Deacon CF. Incretin hormone secretion over the day. Vitam Horm 2010; 84: 203-220.
56. Marina AS, Kutina AV, Shakhmatova EI, Balbotkina EV, Natochin YV. Stimulation of glucagon-like peptide-1 secretion by water loading in human. Dokl Biol Sci 2014; 459: 323-325.